•Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers
•Staging of Gastric Cancer: CT Patterns and Correlation with Pathologic Findings
•PFKM Promotes the Progression of Gastric Cancer by Up-regulating CNTN1 Expression Through H3K18la Modification
•HER2-Positive Urothelial Carcinoma: Current Evidence on Targeted Agents and Immunotherapy-Based Combinations
•Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping: Chemotherapy, Immunotherapy, or Targeted Therapy?-A Retrospective Analysis